Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Wu

Showing results (81-90 of 1,779) with videos related to

Pageof 178
Sort By:
The Journal of Applied Laboratory Medicine|September 17, 2021
Kappa/Lambda Ratio for Early Detection of Multiple Myeloma Relapse Using the Reference Change Value from Biological Variation StudiesAlan H B Wu
Zhonghua Fu Chan Ke Za Zhi|May 12, 2000
[Clinical applications of computer system for diet consultation of pregnant women]B Wu, S Shen
Pharmacogenomics|February 5, 2008
Use of genetic and nongenetic factors in warfarin dosing algorithmsAlan H B Wu
Zhonghua Fu Chan Ke Za Zhi|June 1, 1995
[Epidemiological study on risk factors of pelvic endometriosis]Y Zhou, B Wu
Clinical Laboratory Science : Journal of the American Society for Medical Technology|March 12, 2004
The role of cardiac troponin in the recent redefinition of acute myocardial infarctionAlan H B Wu
Expert Review of Cardiovascular Therapy|December 4, 2009
Pharmacogenomic testing for warfarin dosing: we are ready nowAlan H B Wu
Anesthesia and Analgesia|February 20, 2009
Gender-specific decision limits for cardiac troponin for risk stratification?Alan H B Wu
American Heart Journal|October 31, 2006
Serial testing of B-type natriuretic peptide and NTpro-BNP for monitoring therapy of heart failure: the role of biologic variation in the interpretation of resultsAlan H B Wu
Circulation|October 18, 2006
Cardiac troponin: friend of the cardiac physician, foe to the cardiac patient?Alan H B Wu
Die Pharmazie|July 10, 2010
Pharmacokinetic/pharmacodynamic model-based combination therapy approach to target antibiotic resistant populations emerged from ciprofloxacin exposureB Wu, H Derendorf
Pageof 178

Showing results (81-90 of 1,779) with videos related to

Sort By:
Pageof 178
The Journal of Applied Laboratory Medicine|September 17, 2021
Kappa/Lambda Ratio for Early Detection of Multiple Myeloma Relapse Using the Reference Change Value from Biological Variation StudiesAlan H B Wu
Zhonghua Fu Chan Ke Za Zhi|May 12, 2000
[Clinical applications of computer system for diet consultation of pregnant women]B Wu, S Shen
Pharmacogenomics|February 5, 2008
Use of genetic and nongenetic factors in warfarin dosing algorithmsAlan H B Wu
Zhonghua Fu Chan Ke Za Zhi|June 1, 1995
[Epidemiological study on risk factors of pelvic endometriosis]Y Zhou, B Wu
Clinical Laboratory Science : Journal of the American Society for Medical Technology|March 12, 2004
The role of cardiac troponin in the recent redefinition of acute myocardial infarctionAlan H B Wu
Expert Review of Cardiovascular Therapy|December 4, 2009
Pharmacogenomic testing for warfarin dosing: we are ready nowAlan H B Wu
Anesthesia and Analgesia|February 20, 2009
Gender-specific decision limits for cardiac troponin for risk stratification?Alan H B Wu
American Heart Journal|October 31, 2006
Serial testing of B-type natriuretic peptide and NTpro-BNP for monitoring therapy of heart failure: the role of biologic variation in the interpretation of resultsAlan H B Wu
Circulation|October 18, 2006
Cardiac troponin: friend of the cardiac physician, foe to the cardiac patient?Alan H B Wu
Die Pharmazie|July 10, 2010
Pharmacokinetic/pharmacodynamic model-based combination therapy approach to target antibiotic resistant populations emerged from ciprofloxacin exposureB Wu, H Derendorf
Pageof 178